Your browser doesn't support javascript.
loading
The effect of adding physician recommendation in digitally-enabled outreach for COVID-19 vaccination in socially/economically disadvantaged populations.
Sumar, Kamal; Blue, Lisa; Fatahi, Gina; Sumar, Mehek; Alvarez, Stephanie; Cons, Pedro; Valencia, Nathalie; Williams, Zachary; Bhatti, Atiq; Parthasarathy, Sairam; Doubeni, Chyke A.
Afiliación
  • Sumar K; Adelante Healthcare, Phoenix, AZ, USA.
  • Blue L; Providertech LLC, Phoenix, AZ, USA.
  • Fatahi G; Department of Family and Community Medicine, Ohio State University, Columbus, OH, USA.
  • Sumar M; Division of Biological Sciences, University of California San Diego, San Diego, CA, USA.
  • Alvarez S; Adelante Healthcare, Phoenix, AZ, USA.
  • Cons P; Adelante Healthcare, Phoenix, AZ, USA.
  • Valencia N; Adelante Healthcare, Phoenix, AZ, USA.
  • Williams Z; Adelante Healthcare, Phoenix, AZ, USA.
  • Bhatti A; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA.
  • Parthasarathy S; College of Medicine, University of Arizona, Tucson, AZ, USA.
  • Doubeni CA; Department of Family and Community Medicine, Ohio State University, Columbus, OH, USA. chyke.doubeni@osumc.edu.
BMC Public Health ; 24(1): 1933, 2024 Jul 18.
Article en En | MEDLINE | ID: mdl-39026196
ABSTRACT

INTRODUCTION:

People from backgrounds that are economically/socially disadvantaged experienced disproportionately high COVID-19 death rates and had lower vaccination rates. Effective outreach strategies for increasing vaccine uptake during the pandemic are not fully known. Among patients receiving care at a Federally Qualified Health Center, we tested whether community engaged digitally-enabled outreach from a trusted clinician messenger increased COVID vaccine uptake. STUDY DESIGN, SETTING, AND

PARTICIPANTS:

A 3-parallel-arm randomized controlled trial with a hybrid effectiveness-implementation design was conducted among patients ≥ 18 years old on study enrollment during 2021 with 1,650 assigned in 31020 ratio; 2,328 were later selected for two subsequent implementation rounds.

INTERVENTIONS:

From April 13 to June 10, 2021, patients were proactively sent a text-messaging invitation to make an appointment for vaccination as part of the routine practice with a link to frequently asked questions (Arm 1, n = 150) with added personalized clinician recommendation alone (Arm 2, n = 500) or with enabled 2-way SMS messaging feature (Arm 3, n = 1,000). Further implementation used messaging addressing vaccine hesitancy (n = 1,323) or adverse reactions to vaccines (n = 1,005). MAIN OUTCOMES AND

MEASURES:

The primary outcome was the completion of the first SARS-Cov-2 vaccine dose determined at 14, 30 and 90 days after outreach.

RESULTS:

Of 1,650 patients in effectiveness Arms, 61% was female. Vaccination rates for Arms 1, 2, and 3, were 6% (n = 9), 5.4% (n = 27) and 3.3% (n = 33) at 14 days, and 11.5% (n = 17), 11.6% (n = 58), and 8.5% (n = 85) at 90 days, respectively, which were similar in pairwise comparisons. At 90 days, vaccination rates were similar across the two implementation rounds (3.9% vs. 3.6%) and were similar to the rate (3.3%) among patients who were not selected for intervention arms or implementation rounds (n = 8,671).

CONCLUSIONS:

Digitally-enabled outreach that included SMS messaging outreach augmented with clinician recommendations did not improve COVID-19 vaccination rates. TRIAL REGISTRATION This study is registered at ClinicalTrails.gov Identifier NC-T04952376.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Poblaciones Vulnerables / Envío de Mensajes de Texto / Vacunas contra la COVID-19 / COVID-19 Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Public Health Asunto de la revista: SAUDE PUBLICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Poblaciones Vulnerables / Envío de Mensajes de Texto / Vacunas contra la COVID-19 / COVID-19 Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Public Health Asunto de la revista: SAUDE PUBLICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido